Shubh Goel

Keine laufenden Positionen mehr

51 Jahre

Health Technology

Consumer Services

Ehemalige bekannte Positionen von Shubh Goel

Unternehmen	Position	Beginn	Ende
FENNEC PHARMACEUTICALS INC.	Corporate Officer/Principal	09.09.2019	28.02.2022
CELGENE	Corporate Officer/Principal	01.01.2013	01.01.2017
AVEO PHARMACEUTICALS, INC.	Vertrieb & Marketing	01.01.2011	01.01.2013
BAYER AG	Corporate Officer/Principal	01.01.2007	01.01.2011
ODONATE, INC.	Geschäftsführer	01.12.2017	19.11.2018
ODONATE, INC.	Corporate Officer/Principal	19.11.2018	-

University of Bath

Undergraduate Degree

International

Operativ

Corporate Officer/Principal	4
Chief Operating Officer	1
Sales & Marketing	1

Sektoral

Health Technology	6
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	3
ODONATE, INC.	Health Technology
BAYER AG	Health Technology
FENNEC PHARMACEUTICALS INC.	Health Technology

Private Unternehmen	2
Celgene Corp. Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ.	Health Technology
AVEO Pharmaceuticals, Inc. AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA.	Health Technology

Private Unternehmen

Health Technology